Misplaced Pages

Synaptic pharmacology

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Synaptic Pharmacology)
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (February 2021) (Learn how and when to remove this message)
This article may be too technical for most readers to understand. Please help improve it to make it understandable to non-experts, without removing the technical details. (February 2021) (Learn how and when to remove this message)
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Synaptic pharmacology" – news · newspapers · books · scholar · JSTOR (February 2021) (Learn how and when to remove this message)
(Learn how and when to remove this message)

Synaptic pharmacology is the study of drugs that act on the synapses. It deals with the composition, uses, and effects of drugs that may enhance (receptor) or diminish (blocker) activity at the synapse, which is the junction across which a nerve impulse passes from an axon terminal to a neuron, muscle cell, or gland cell.

A partial list of pharmacological agents that act at synapses follows.

Synaptic pharmacology
Channel, Receptor, or Phenomenon Antagonist or Blocker
adenosine DCPGX, ZM241385, anoxinine
AMPA-R NBQX
AMPA-R desensitization cyclothiazide (CTZ)
cannabinoid AM-251
GABAA bicuculline, gabazine
GABAB CGP-54626
glycine strychnine
kainate R ..
metabotropic GluR, broad MCPG, pertussis toxin, NEM
muscarinic AChR atropine, Scopolamine
nicotinic AChR bungarotoxin, curare, DhBe
NMDA-R APV

References

  1. ^ Ueno S, Bracamontes J, Zorumski C, Weiss DS, Steinbach JH (15 January 1997). "Bicuculline and gabazine are allosteric inhibitors of channel opening of the GABAA receptor". J. Neurosci. 17 (2): 625–34. doi:10.1523/jneurosci.17-02-00625.1997. PMC 6573228. PMID 8987785.
  2. Frenguelli BG, Potier B, Slater NT, Alford S, Collingridge GL (November 1993). "Metabotropic glutamate receptors and calcium signalling in dendrites of hippocampal CA1 neurones". Neuropharmacology. 32 (11): 1229–37. doi:10.1016/0028-3908(93)90017-W. PMID 7906405. S2CID 13008430.
Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: